Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Aug 26;48(1):155.
doi: 10.1186/s13052-022-01343-1.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy

Affiliations
Observational Study

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy

Angela Pepe et al. Ital J Pediatr. .

Abstract

Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic has been challenging health care systems and made it necessary to use rapid and cost-effective testing methods, particularly in Emergency Department (ED) settings. Rapid Antigen Diagnostic Tests (RADTs) are a valid alternative to the gold standard RT-PCR, even in pediatric populations. This retrospective observational study has been conducted on a pediatric cohort afferent to the ED of the San Giovanni di Dio and Ruggi d'Aragona University Hospital in Salerno, tested at Point of Care with RADT Panbio® (Abbott), from September 1st, 2021 to February 28th, 2022, analyzing the positivity rate and clinical features of the cohort, also in reference to the rise of positive cases observed in the aforementioned period, and to the introduction in Italy of SARS-CoV-2 vaccination for children and teens on December 16th, 2021.

Methods: Data regarding access to the pediatric ED were extracted from the hospital's electronic database system. Parallel to this, we conducted a narrative literature search using PubMed database focusing on the use of RADT in pediatric ED and compared our data with the national pandemic trend.

Results: During the observation period, 1890 patients were tested for the presence of SARS-CoV-2 with RADT and the 2.7% of children resulted positive, with a peak in January 2022. The main symptoms in positive patients were: fever (n = 34; 66.7%), cough (n = 11; 21.5%), headache (n = 4; 7.8%), chest pain (n = 2; 3.9%) and abdominal pain (n = 1; 2%). Patients were divided into three different age groups (A, B, C) basing on the different access timing to vaccination; no statistically significant difference was detected in the distribution of positivity in these three groups (p > 0.05). Number of positive children in group A was greater in the post-vaccine group. Our data are concordant with the national trend of the pandemic showing a fourth wave peak in January 2022.

Conclusion: The use of RADT as a first point-of-care screening may be helpful, time-saving and cost-sparing. Our study shows that, during the observation period, most children admitted to the ED for fever, actually tested positive for SARS-CoV-2 with a statistically greater difference than negative children. Instead, number of patients admitted for cough was statistically higher among negative than positive ones, probably due to the circulation of other respiratory viruses in children.

Keywords: Children; Emergency department; Rapid antigen diagnostic tests (RADTs); SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of patients enrolled in this study. During the observation period, 1904 pediatric patients were admitted to the Emergency Department (ED) of the San Giovanni di Dio and Ruggi d’Aragona University Hospital in Salerno and 1890 were tested for the presence of SARS-CoV-2 with Rapid Antigen Test. Fourteen patients did not perform the test because left the ED before visiting and were therefore excluded from the study
Fig. 2
Fig. 2
Number of accesses to the Emergency Department (ED). The significant difference (p < 0.01) in the number of accesses pre / post expansion of the vaccination campaign in groups A and C is demonstrated with *
Fig. 3
Fig. 3
Distribution of positive patients in groups A, B, C. Differences between groups were not significant (p > 0.05)
Fig. 4
Fig. 4
Cases distribution in the observation period (top figure) and Italian trend of the pandemic (bottom figure). As shown in the figures, the peak of positive cases in both our cohort and national trend occurred in January 2022
Fig. 5
Fig. 5
Flow diagram regarding study selection

Similar articles

References

    1. Mauro A, Improda N, Zenzeri L, Valitutti F, Vecchione E, Esposito S, et al. Infection control strategy and primary care assistance in Campania region during the national lockdown due to COVID-19 outbreak: the experience of two tertiary emergency centers. Ital J Pediatr. 2021;47:19. doi: 10.1186/s13052-021-00963-3. - DOI - PMC - PubMed
    1. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020:25. 10.2807/1560-7917.ES.2020.25.3.2000045. - PMC - PubMed
    1. Carbonell-Sahuquillo S, Lázaro-Carreño MI, Camacho J, Barrés-Fernández A, Albert E, Torres I, et al. Evaluation of a rapid antigen detection test (Panbio™ COVID-19 ag rapid test device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department. J Med Virol. 2021;93:6803–6807. doi: 10.1002/jmv.27220. - DOI - PMC - PubMed
    1. Reichert F, Enninger A, Plecko T, Zoller WG, Paul G. Pooled SARS-CoV-2 antigen tests in asymptomatic children and their caregivers: screening for SARS-CoV-2 in a pediatric emergency department. Am J Infect Control. 2021;49:1242–1246. doi: 10.1016/j.ajic.2021.07.009. - DOI - PMC - PubMed
    1. Villaverde S, Domínguez-Rodríguez S, Sabrido G, Pérez-Jorge C, Plata M, Romero MP, et al. Diagnostic accuracy of the Panbio severe acute respiratory syndrome coronavirus 2 antigen rapid test compared with reverse-transcriptase polymerase chain reaction testing of nasopharyngeal samples in the pediatric population. J Pediatr. 2021;232:287–289. doi: 10.1016/j.jpeds.2021.01.027. - DOI - PMC - PubMed

Publication types

Substances